education and awareness related to COVID-19 therapeutics
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2025 | INVIVYD, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$20,000 | |
| 2025 | INVIVYD, INC. |
4th Quarter (Oct 1 - Dec 31) AMENDED |
— |
| Firm | Filings | Expenses |
|---|---|---|
| INVIVYD, INC. | 14 | $200,000 |
| Issue | Activities |
|---|---|
| Health Issues | 11 |
| Medical/Disease Research/Clinical Labs | 9 |